| Late onset ipilimumab‐induced pericarditis and pericardial effusion: a rare but life threatening complication S Yun, ND Vincelette, I Mansour, D Hariri, S Motamed Case reports in oncological medicine 2015 (1), 794842, 2015 | 142 | 2015 |
| BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis M Oh, A McBride, S Yun, S Bhattacharjee, M Slack, JR Martin, J Jeter, ... JNCI: Journal of the National Cancer Institute 110 (11), 1178-1189, 2018 | 140 | 2018 |
| Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies M Gupta, AEW Hendrickson, SS Yun, JJ Han, PA Schneider, BD Koh, ... Blood, The Journal of the American Society of Hematology 119 (2), 476-487, 2012 | 121 | 2012 |
| Targeting immune checkpoints in unresectable metastatic cutaneous melanoma: a systematic review and meta‐analysis of anti‐CTLA‐4 and anti‐PD‐1 agents trials S Yun, ND Vincelette, MR Green, AE Wahner Hendrickson, I Abraham Cancer medicine 5 (7), 1481-1491, 2016 | 119 | 2016 |
| Risk of atrial fibrillation and bleeding diathesis associated with ibrutinib treatment: a systematic review and pooled analysis of four randomized controlled trials S Yun, ND Vincelette, U Acharya, I Abraham Clinical Lymphoma Myeloma and Leukemia 17 (1), 31-37. e13, 2017 | 105 | 2017 |
| Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapy UH Acharya, T Dhawale, S Yun, CA Jacobson, JC Chavez, JD Ramos, ... Expert Review of Hematology 12 (3), 195-205, 2019 | 80 | 2019 |
| Brentuximab vedotin for treatment of non-Hodgkin lymphomas: a systematic review GK Berger, A McBride, S Lawson, K Royball, S Yun, K Gee, IB Riaz, ... Critical reviews in oncology/hematology 109, 42-50, 2017 | 79 | 2017 |
| Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials S Yun, ND Vincelette, I Abraham, KD Robertson, ME Fernandez-Zapico, ... Clinical epigenetics 8, 1-9, 2016 | 72 | 2016 |
| Update on iron metabolism and molecular perspective of common genetic and acquired disorder, hemochromatosis S Yun, ND Vincelette Critical reviews in oncology/hematology 95 (1), 12-25, 2015 | 72 | 2015 |
| Cardioprotective role of β-blockers and angiotensin antagonists in early-onset anthracyclines-induced cardiotoxicity in adult patients: a systematic review and meta-analysis S Yun, ND Vincelette, I Abraham Postgraduate medical journal 91 (1081), 627-633, 2015 | 67 | 2015 |
| Waldenström macroglobulinemia: review of pathogenesis and management S Yun, AC Johnson, ON Okolo, SJ Arnold, A McBride, L Zhang, RC Baz, ... Clinical Lymphoma Myeloma and Leukemia 17 (5), 252-262, 2017 | 60 | 2017 |
| Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes AM Hunter, RS Komrokji, S Yun, N Al Ali, O Chan, J Song, M Hussaini, ... Blood advances 5 (4), 1017-1028, 2021 | 53 | 2021 |
| 4EBP1/c-MYC/PUMA and NF-κB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells S Yun, ND Vincelette, KLB Knorr, LL Almada, PA Schneider, KL Peterson, ... Blood, The Journal of the American Society of Hematology 127 (22), 2711-2722, 2016 | 52 | 2016 |
| Comparative effectiveness of newer tyrosine kinase inhibitors versus imatinib in the first-line treatment of chronic-phase chronic myeloid leukemia across risk groups: a … S Yun, ND Vincelette, JM Segar, Y Dong, Y Shen, DW Kim, I Abraham Clinical Lymphoma Myeloma and Leukemia 16 (6), e85-e94, 2016 | 47 | 2016 |
| Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant S Yun, O Chan, D Kerr, ND Vincelette, A Idrees, Q Mo, K Sweet, JE Lancet, ... Blood advances 4 (14), 3435-3442, 2020 | 41 | 2020 |
| Cost-effectiveness of anticoagulants for suspected heparin-induced thrombocytopenia in the United States A Aljabri, Y Huckleberry, JH Karnes, M Gharaibeh, HI Kutbi, Y Raz, S Yun, ... Blood, The Journal of the American Society of Hematology 128 (26), 3043-3051, 2016 | 40 | 2016 |
| Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML) S Yun, SM Geyer, RS Komrokji, NH Al Ali, J Song, M Hussaini, KL Sweet, ... Leukemia 35 (4), 1145-1155, 2021 | 39 | 2021 |
| Impact of region of diagnosis, ethnicity, age, and gender on survival in acute myeloid leukemia (AML) UH Acharya, AB Halpern, Q Wu, JM Voutsinas, RB Walter, S Yun, ... Journal of drug assessment 7 (1), 51-53, 2018 | 38 | 2018 |
| Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells H Ding, JS McDonald, S Yun, PA Schneider, KL Peterson, KS Flatten, ... Haematologica 99 (1), 60, 2014 | 38 | 2014 |
| Prognostic significance of MYC oncoprotein expression on survival outcome in patients with acute myeloid leukemia with myelodysplasia related changes (AML-MRC) S Yun, R Sharma, O Chan, ND Vincelette, DA Sallman, K Sweet, ... Leukemia research 84, 106194, 2019 | 29 | 2019 |
Nicole VinceletteMoffitt Cancer Center在 moffitt.org 的电子邮件经过验证
